Skip to main content
. 2026 Aug 6;67(5):810–819. doi: 10.1093/jrr/rrag060

Table 2.

Results of univariate analysis for predicting local recurrence

n Local control rate P value
Age <64.5 46 0.855 0.889
≧64.5 27 0.830
Tumor size <4.0 17 0.933 0.267
≧4.0 56 0.819
FIGO 2018 I or II 39 0.827 0.668
III or IV 34 0.865
Histology SCC 61 0.838 0.599
Others 12 0.889
EQD2 <85 Gy 64 0.824 0.213
≧85 Gy 9 1.000
RECIST CR 62 0.852 0.549
PR 11 0.818
PERCIST CMR 58 0.896 0.013
PMR or SMD 15 0.667
Metabolic response CMR 45 0.923 0.035
PMR 28 0.730
Pre-treatment MTV <73.3 50 0.910 0.031
≧73.3 23 0.712
Pre-treatment SUVmax <17.7 54 0.853 0.765
≧17.7 19 0.825
Pre-treatment TLG <703.6 57 0.902 0.014
≧703.6 16 0.641
Post-treatment MTV <5.0 56 0.932 <0.001
≧5.0 17 0.588
Post-treatment SUVmax <4.2 65 0.909 <0.001
≧4.2 8 0.375
Post-treatment TLG <15.1 65 0.909 <0.001
≧15.1 8 0.375

SCC = squamous cell carcinoma, EQD2 = Equivalent Dose in 2 Gy fractions, CMR = complete metabolic response, PMR = partial metabolic response, SMD = stable metabolic disease